Form 8-K - Current report:
SEC Accession No. 0000950170-25-103058
Filing Date
2025-08-05
Accepted
2025-08-05 16:15:36
Documents
12
Period of Report
2025-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adpt-20250805.htm   iXBRL 8-K 54360
2 EX-99.1 adpt-ex99_1.htm EX-99.1 475818
3 GRAPHIC img119828894_0.jpg GRAPHIC 7887
  Complete submission text file 0000950170-25-103058.txt   675382

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20250805.xsd EX-101.SCH 30680
14 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20250805_htm.xml XML 4773
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)